Qiang Wan
Luzhou, 646000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Development and Evaluation of [68Ga]Ga-DOTA-BT1718: A Novel Imaging Agent Targeting MT1-MMP for Malignant Tumor Diagnosis.
Journal: Journal of medicinal chemistry
Published: August 25, 2025
Development of 18F-Labeled Positron Emission Tomography Agents Targeting Fibroblast Activation Protein.
Journal: Molecular pharmaceutics
Published: May 07, 2025
Preliminary Study of Radionuclide-Labeled MerTK-Targeting PET Imaging Agents for the Diagnosis of Melanoma.
Journal: Journal of medicinal chemistry
Published: November 01, 2024
Effects of PEGylation on Imaging Contrast of 68Ga-Labeled Bicyclic Peptide PET Probes Targeting Nectin-4.
Journal: Molecular pharmaceutics
Published: July 29, 2024
A comparison of [18F]AlF- and 68Ga-labeled dual targeting heterodimer FAPI-RGD in malignant tumor: preclinical evaluation and pilot clinical PET/CT imaging.
Journal: European journal of nuclear medicine and molecular imaging
Published: October 16, 2023
Prospective comparison of 68Ga-FAPI-04 and 18F-FDG PET/CT for tumor staging in nasopharyngeal carcinoma.
Journal: Frontiers in oncology
Published: September 17, 2022
Radionuclide-Labeled Peptides for Imaging and Treatment of CXCR4- Overexpressing Malignant Tumors.
Journal: Current topics in medicinal chemistry
Published: October 01, 2018
Comparison of 18F-NaF PET/CT and 18F-FDG PET/CT for Detection of Skull-Base Invasion and Osseous Metastases in Nasopharyngeal Carcinoma.
Journal: Contrast media & molecular imaging
Published: April 03, 2018
18F-NaF PET/CT Finding in a Patient With Abdominal Discomfort After Schistosomiasis.
Journal: Clinical nuclear medicine
Published: January 23, 2018
Last Updated: 09/26/2026